Position in PTGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$488,355
+$82,567 QoQ
Shares Held
3,984
+3.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#211
of 341 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026M&T Bank Corp holds $45,025,387 across 46 Biotechnology names. PTGX ranks #24 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,959 | $6,933,847 | |
| 2 | ARGX |
Argenx SE
|
4,343 | $4,029,301 | |
| 3 | TECH |
BIO-TECHNE Corp
|
41,878 | $2,958,677 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,576 | $2,853,313 | |
| 5 | MRNA |
Moderna, Inc.
|
36,733 | $2,572,408 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,071 | $2,429,608 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
28,231 | $2,209,634 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
9,451 | $1,769,980 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $488,355 | 3,984 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $405,788 | 3,850 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $327,783 | 3,753 | Shares | Defined | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||